These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 22232050)

  • 1. Nicotine treatment of mild cognitive impairment: a 6-month double-blind pilot clinical trial.
    Newhouse P; Kellar K; Aisen P; White H; Wesnes K; Coderre E; Pfaff A; Wilkins H; Howard D; Levin ED
    Neurology; 2012 Jan; 78(2):91-101. PubMed ID: 22232050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transdermal Nicotine for the Treatment of Mood and Cognitive Symptoms in Nonsmokers With Late-Life Depression.
    Gandelman JA; Kang H; Antal A; Albert K; Boyd BD; Conley AC; Newhouse P; Taylor WD
    J Clin Psychiatry; 2018 Aug; 79(5):. PubMed ID: 30192444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transdermal nicotine on attention in adult non-smokers with and without attentional deficits.
    Poltavski DV; Petros T
    Physiol Behav; 2006 Mar; 87(3):614-24. PubMed ID: 16466655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic transdermal nicotine patch treatment effects on cognitive performance in age-associated memory impairment.
    White HK; Levin ED
    Psychopharmacology (Berl); 2004 Feb; 171(4):465-71. PubMed ID: 14534771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls.
    Barr RS; Culhane MA; Jubelt LE; Mufti RS; Dyer MA; Weiss AP; Deckersbach T; Kelly JF; Freudenreich O; Goff DC; Evins AE
    Neuropsychopharmacology; 2008 Feb; 33(3):480-90. PubMed ID: 17443126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of transdermal nicotine on prose memory and attention in smokers and nonsmokers.
    Poltavski DV; Petros T
    Physiol Behav; 2005 Jan; 83(5):833-43. PubMed ID: 15639169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Four-week nicotine skin patch treatment effects on cognitive performance in Alzheimer's disease.
    White HK; Levin ED
    Psychopharmacology (Berl); 1999 Apr; 143(2):158-65. PubMed ID: 10326778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.
    Steiner GZ; Bensoussan A; Liu J; Hohenberg MI; Chang DH
    Trials; 2018 Sep; 19(1):522. PubMed ID: 30253809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lower but not higher doses of transdermal nicotine facilitate cognitive performance in smokers on gender non-preferred tasks.
    Poltavski DV; Petros TV; Holm JE
    Pharmacol Biochem Behav; 2012 Sep; 102(3):423-33. PubMed ID: 22691869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial.
    Shin HY; Kim HR; Jahng GH; Jin C; Kwon S; Cho SY; Park SU; Jung WS; Moon SK; Ko CN; Park JM
    BMC Complement Med Ther; 2021 Oct; 21(1):251. PubMed ID: 34620151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of transdermal nicotine on episodic memory in non-smokers with and without schizophrenia.
    Jubelt LE; Barr RS; Goff DC; Logvinenko T; Weiss AP; Evins AE
    Psychopharmacology (Berl); 2008 Jul; 199(1):89-98. PubMed ID: 18548234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of efficacy of a nicotine transdermal treatment on motor and cognitive deficits in Parkinson's disease.
    Lemay S; Chouinard S; Blanchet P; Masson H; Soland V; Beuter A; Bédard MA
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):31-9. PubMed ID: 14687854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.
    Craft S; Baker LD; Montine TJ; Minoshima S; Watson GS; Claxton A; Arbuckle M; Callaghan M; Tsai E; Plymate SR; Green PS; Leverenz J; Cross D; Gerton B
    Arch Neurol; 2012 Jan; 69(1):29-38. PubMed ID: 21911655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effectiveness and safety of Kami Guibi-tang for mild cognitive impairment: study protocol of a pilot, randomized, placebo-controlled, double-blind trial.
    Shin HY; Kim JH; Jahng GH; Jung WS; Park SU; Ko CN; Park JM
    Trials; 2019 Jul; 20(1):448. PubMed ID: 31331367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute nicotine improves cognitive deficits in young adults with attention-deficit/hyperactivity disorder.
    Potter AS; Newhouse PA
    Pharmacol Biochem Behav; 2008 Feb; 88(4):407-17. PubMed ID: 18022679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal nicotine effects on attention.
    Levin ED; Conners CK; Silva D; Hinton SC; Meck WH; March J; Rose JE
    Psychopharmacology (Berl); 1998 Nov; 140(2):135-41. PubMed ID: 9860103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal nicotine and haloperidol in Tourette's disorder: a double-blind placebo-controlled study.
    Silver AA; Shytle RD; Philipp MK; Wilkinson BJ; McConville B; Sanberg PR
    J Clin Psychiatry; 2001 Sep; 62(9):707-14. PubMed ID: 11681767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of nicotine on response inhibition and interference control.
    Ettinger U; Faiola E; Kasparbauer AM; Petrovsky N; Chan RC; Liepelt R; Kumari V
    Psychopharmacology (Berl); 2017 Apr; 234(7):1093-1111. PubMed ID: 28150023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of a nicotine (4 mg)-containing lozenge on the cognitive impairment of nicotine withdrawal.
    Atzori G; Lemmonds CA; Kotler ML; Durcan MJ; Boyle J
    J Clin Psychopharmacol; 2008 Dec; 28(6):667-74. PubMed ID: 19011436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study.
    Mamikonyan E; Xie SX; Melvin E; Weintraub D
    Mov Disord; 2015 Jun; 30(7):912-8. PubMed ID: 25914281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.